Eisai: "LEQEMBI" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in China Eisai Jan 10, 2024 09:15 HKT/SGT Read More
Transgene and NEC Extend their Collaboration to Continue Joint Clinical Development of Neoantigen Cancer Vaccine TG4050 NEC Corporation Jan 09, 2024 15:30 HKT/SGT Read More
CMS(00867) Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEA China Medical System Holdings Ltd. Jan 02, 2024 15:00 JST Read More
Development of Prediction Model for Brain Amyloid-Beta Accumulation Using Wristband Sensor Eisai Dec 29, 2023 13:30 HKT/SGT Read More
Eisai Submits Marketing Authorization Application in Japan for Anticancer Agent Tasurgratinib for Biliary Tract Cancer with Fgfr2 Gene Fusion Eisai Dec 19, 2023 16:24 HKT/SGT Read More
Eisai and Mizuho Sign Sustainability-Linked Loan Agreement Eisai Dec 14, 2023 17:02 HKT/SGT Read More
"LEQEMBI Intravenous Infusion" (Lecanemab) for the Treatment of Alzheimer's Disease to be Launched in Japan on December 20 Eisai Dec 14, 2023 15:39 HKT/SGT Read More
China Medical System: 4 Products Have Been Newly Included or Continued to be Included in the NRDL China Medical System Holdings Ltd. Dec 13, 2023 18:36 JST Read More
TANAKA Contributes to Global Vascular, a Medical Venture Company Developing a Stent Delivery System for Lower Limb Atherosclerosis TANAKA PRECIOUS METAL GROUP Co., Ltd. Dec 13, 2023 03:00 HKT/SGT Read More
Olympus Named to Dow Jones Sustainability World Index for Three Consecutive Years Olympus Dec 11, 2023 10:00 HKT/SGT Read More
Eisai and Merck & Co., Inc., Rahway, NJ, USA Provide Update on Phase 3 LEAP-001 Trial Evaluating LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) as First-Line Treatment for Patients with Advanced or Recurrent Endometrial Carcinoma Eisai Dec 11, 2023 09:28 HKT/SGT Read More
Fujitsu joins Japan Health & Productivity Management Alliance Fujitsu Ltd Dec 11, 2023 09:10 HKT/SGT Read More
Vesica AI Selected as Winner of Inaugural Olympus Asia Pacific Innovation Program Olympus Dec 07, 2023 10:00 HKT/SGT Read More
China Medical System: NDA for Additional RA Indication of Methotrexate Injection Accepted in China China Medical System Holdings Ltd. Dec 04, 2023 22:52 JST Read More
Eisai's Sales Subsidiary Collaborates with Ministry of Public Health (MOPH) in Thailand Eisai Nov 30, 2023 15:25 HKT/SGT Read More
Eisai to Present Latest Data on Perampanel at The 77th American Epilepsy Society (AES) Annual Meeting Eisai Nov 22, 2023 08:28 HKT/SGT Read More
LEQEMBI Wins Best New Drug And Clinical Advance of The Year at The Scrip Awards 2023 Eisai Nov 20, 2023 16:05 HKT/SGT Read More
Fujitsu to license Topological Data Analysis technology to Delight Health, a Bay Area startup focused on providing innovative mental health solutions Fujitsu Ltd Nov 20, 2023 09:15 HKT/SGT Read More
